Swiss All Share Index
17.970,97
PKT
-10,34
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.04.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 04.04.18 | Swiss Re Sell | UBS AG | |
| 04.04.18 | Swiss Re buy | Baader Bank | |
| 04.04.18 | Nestlé Outperform | RBC Capital Markets | |
| 03.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.04.18 | Roche overweight | JP Morgan Chase & Co. | |
| 03.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.04.18 | Nestlé Neutral | UBS AG | |
| 03.04.18 | UBS buy | UBS AG | |
| 29.03.18 | Zurich Insurance Neutral | UBS AG | |
| 29.03.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 29.03.18 | Swiss Re overweight | Barclays Capital | |
| 29.03.18 | Swiss Re Sector Perform | RBC Capital Markets | |
| 29.03.18 | Roche Hold | Deutsche Bank AG | |
| 28.03.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
| 28.03.18 | Zurich Insurance Equal weight | Barclays Capital | |
| 28.03.18 | Novartis Hold | Deutsche Bank AG | |
| 27.03.18 | Novartis buy | S&P Capital IQ | |
| 27.03.18 | Novartis buy | Baader Bank | |
| 27.03.18 | Novartis Neutral | UBS AG | |
| 27.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 27.03.18 | UBS Outperform | Credit Suisse Group | |
| 27.03.18 | Givaudan Hold | Kepler Cheuvreux | |
| 27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.03.18 | Roche overweight | JP Morgan Chase & Co. | |
| 27.03.18 | Nestlé overweight | JP Morgan Chase & Co. | |
| 27.03.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 27.03.18 | Roche Underweight | Morgan Stanley | |
| 27.03.18 | Givaudan Hold | Deutsche Bank AG | |
| 26.03.18 | Nestlé Outperform | RBC Capital Markets | |
| 26.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 23.03.18 | UBS overweight | Morgan Stanley | |
| 23.03.18 | Roche buy | Jefferies & Company Inc. | |
| 23.03.18 | Swiss Re buy | Deutsche Bank AG | |
| 21.03.18 | Roche Hold | Deutsche Bank AG | |
| 21.03.18 | Holcim Hold | Deutsche Bank AG | |
| 21.03.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.03.18 | Roche Neutral | UBS AG |